GenVec, Inc. (GNVC)

Stock Picks, Featured Profiles, Stock Updates, Stock Information, Intraday Stock Alerts, Daily Stock Analysis

RockingStocks.com Stock Picks

Your browser does not support inline frames or is currently configured not to display inline frames.

September 16, 2009

Rockin' Stock Pick: GenVec, Inc. (GNVC)

Stock Price: $0.81

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer.

GNVC's lead product, TNFerade(TM) is currently in a Phase III study for locally advanced pancreatic cancer. TNFerade(TM) is also being explored for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer.

GNVC just received notification from the NASDAQ that they must meet or exceed $1.00 per share for at least ten consecutive business days. We believe GNVC will be able to meet this requirement. The company has 180 calendar days to regain compliance. GNVC is up from its lows below $0.35 earlier in the year.

GNVC has seen a nice amount of interest over the last six trading days between $0.76 and $0.86. Volume has been strong for GNVC. However, we believe GNVC is still under the radar with only a 12.80% institutional interest and trading at a market cap of only around $80 million.

GNVC's management team has significant experience. GNVC has around $12.6 million in cash, cash equivalents and short-term investments.

Disclosure: RockingStocks.com is owned by SpeculatingStocks.com, Inc. SpeculatingStocks.com, Inc. is not a registered investment adviser or broker/dealer. SpeculatingStocks.com, Inc. makes no recommendation that the purchase of securities of companies profiled in this Web site are suitable or advisable for any person or that an investment in such securities will be profitable. Generally, given the nature of the companies profiled and the possible lack of liquidity for their securities, investing in such securities is highly speculative and carries a high degree of risk. Never invest based solely on information from this Web site or our email alerts.

DISCLAIMER & RISK DISCLOSURE: RockingStocks.com and SpeculatingStocks.com, Inc. and our affiliates ("our companies") are not registered investment advisers or broker/dealers. Our companies make no commitment that the purchase of securities of companies profiled or otherwise mentioned in our websites are suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the possible lack of liquidity for their securities, investing in such securities is highly speculative and carries a high degree of risk. Never invest based solely on information from this Web site or our email alerts. Our RockingStocks.com Newsletter is our free alert email membership. We profile selected companies on our site. These companies compensate SpeculatingStocks.com, Inc. for profile coverage. This compensation can be found in the disclosure on the bottom of the page of profiles. This Disclaimer & Risk Disclosure is also at the bottom of profiles. Specific questions on membership or profiles can be obtained by writing RockingStocks.com at: staff@rockingstocks.com.